Concepedia

Publication | Closed Access

MFAP4: a candidate biomarker for hepatic and pulmonary fibrosis?

25

Citations

0

References

2016

Year

Christian Mölleken, Gereon Poschmann, Francesco Bonella, Ulrich Costabel, Barbara Sitek, Kai Stühler, Helmut E. Meyer, Wolff Schmiegel, Niels Marcussen, M. Helmer,
PubMed

Abstract

MFAP4 is not elevated in sera of patients with pulmonary fibrosis or bleomycin treated mice with pulmonary fibrosis. This may be due to different pathogenic mechanisms of liver and lung fibrogenesis. MFAP4 seems to be useful as serum biomarker for hepatic but not for lung fibrosis.